Read about the members who drive innovation at ARMI | BioFabUSA.
Member Spotlight: Theradaptive
Luis Alvarez envisions a day when therapeutic proteins that hasten cellular development can be delivered with high precision and long duration to drive the regeneration of entire tissues, and when
Member Spotlight: Ronawk
A.J. Mellott remembers exactly when the idea for growing cells in a micro-channeled hydrogel hit him. He was a graduate student, and he was working endlessly to grow cell cultures
Member Spotlight: Air Logic
When a regenerative medicine startup included his company’s orifice restrictor to control the flow rate of a liquid in its production process, John Hayden started asking around about other companies
Member Spotlight: ChromoLogic
ChromoLogic, developers of cell therapy and researchers of disease treatment, became a member of BioFabUSA after an introduction at the 2019 Defense Manufacturing Conference. The two have now merged ecosystems.
Member Spotlight: Colorado State University
A chance meeting at the International Conference on Biofabrication led one of the nation’s top research institutions to become a BioFabUSA member.
Member Spotlight: Nanostring
NanoString is a leading provider of life science tools for translational research. The company’s nCounter®Analysis System has been employed in life science research since 2008 and has been cited in more than 4,000 peer-reviewed publications.
Member Spotlight: MTF Biologics and IIAM
MTF Biologics provides safe, high-quality tissue grafts from donated human tissues for orthopedics, plastic and reconstructive surgery, wound care, and regenerative medicine. International Institute for the Advancement of Medicine (IIAM), a division of MTF Biologics, provides non-transplantable organs and tissues to the medical research community
Member Spotlight: Apsis Healthcare Systems
Apsis Healthcare Systems is a Process Analytical Technology organization that brings together a suite of technology aimed at advancing the state of manufacturing in the biologics, cell therapy and regenerative medicine industries.
Member Spotlight: CollPlant
CollPlant’s revolutionary plant-based technology is the only commercially viable technology for mass production of Type I recombinant human (rhCollagen), which is identical to the collagen produced by the human body.